Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Marshall

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Oncology (Williston Park, N.Y.)|April 6, 2010
Fighting a smarter war on cancerJohn L Marshall
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Cases in the management of metastatic colorectal cancer: use of regorafenib as a bridge to chemotherapyJohn L Marshall
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Metastatic colorectal cancer: strategies for third-line treatmentJohn L Marshall
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Maximum-tolerated dose, optimum biologic dose, or optimum clinical value: dosing determination of cancer therapiesJohn L Marshall
Oncology (Williston Park, N.Y.)|January 22, 2016
Adjuvant Therapy After Resection of Metastatic Colorectal Cancer: Scant Evidence of a Curative BenefitJohn L Marshall
Oncology (Williston Park, N.Y.)|January 7, 2006
Novel vaccines for the treatment of gastrointestinal cancersJohn L Marshall
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Time to shift the focus of the war: it is not all about the enemyJohn L Marshall
Gastrointestinal Cancer Research : GCR|April 4, 2009
ISGIO and the Future of GI Oncology: A Very Different Society Making a Very Important DifferenceJohn L Marshall
Oncology (Williston Park, N.Y.)|March 16, 2010
Risk assessment in Stage II colorectal cancerJohn L Marshall
Clinical Advances in Hematology & Oncology : H&O|November 16, 2019
Options for patients with metastatic colorectal cancer who progress after second-line therapyJohn L Marshall
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Oncology (Williston Park, N.Y.)|April 6, 2010
Fighting a smarter war on cancerJohn L Marshall
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Cases in the management of metastatic colorectal cancer: use of regorafenib as a bridge to chemotherapyJohn L Marshall
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Metastatic colorectal cancer: strategies for third-line treatmentJohn L Marshall
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Maximum-tolerated dose, optimum biologic dose, or optimum clinical value: dosing determination of cancer therapiesJohn L Marshall
Oncology (Williston Park, N.Y.)|January 22, 2016
Adjuvant Therapy After Resection of Metastatic Colorectal Cancer: Scant Evidence of a Curative BenefitJohn L Marshall
Oncology (Williston Park, N.Y.)|January 7, 2006
Novel vaccines for the treatment of gastrointestinal cancersJohn L Marshall
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Time to shift the focus of the war: it is not all about the enemyJohn L Marshall
Gastrointestinal Cancer Research : GCR|April 4, 2009
ISGIO and the Future of GI Oncology: A Very Different Society Making a Very Important DifferenceJohn L Marshall
Oncology (Williston Park, N.Y.)|March 16, 2010
Risk assessment in Stage II colorectal cancerJohn L Marshall
Clinical Advances in Hematology & Oncology : H&O|November 16, 2019
Options for patients with metastatic colorectal cancer who progress after second-line therapyJohn L Marshall
Pageof 20